BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10232408)

  • 21. Dominant dystrophic epidermolysis bullosa (Pasini) caused by a novel glycine substitution mutation in the type VII collagen gene (COL7A1).
    Jonkman MF; Moreno G; Rouan F; Oranje AP; Pulkkinen L; Uitto J
    J Invest Dermatol; 1999 May; 112(5):815-7. PubMed ID: 10233777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa.
    Kim M; Murrell DF
    Eur J Dermatol; 2015 Apr; 25 Suppl 1():30-2. PubMed ID: 26083672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes.
    Varki R; Sadowski S; Uitto J; Pfendner E
    J Med Genet; 2007 Mar; 44(3):181-92. PubMed ID: 16971478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identical glycine substitution mutations in type VII collagen may underlie both dominant and recessive forms of dystrophic epidermolysis bullosa.
    Almaani N; Liu L; Dopping-Hepenstal PJ; Lai-Cheong JE; Wong A; Nanda A; Moss C; Martinéz AE; Mellerio JE; McGrath JA
    Acta Derm Venereol; 2011 May; 91(3):262-6. PubMed ID: 21448560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent nonsense mutations within the type VII collagen gene in patients with severe recessive dystrophic epidermolysis bullosa.
    Hovnanian A; Hilal L; Blanchet-Bardon C; de Prost Y; Christiano AM; Uitto J; Goossens M
    Am J Hum Genet; 1994 Aug; 55(2):289-96. PubMed ID: 8037207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dilemmas in distinguishing between dominant and recessive forms of dystrophic epidermolysis bullosa.
    Mallipeddi R; Bleck O; Mellerio JE; Ashton GH; Eady RA; McGrath JA
    Br J Dermatol; 2003 Oct; 149(4):810-8. PubMed ID: 14616374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycine substitution mutations by different amino acids in the same codon of COL7A1 lead to heterogeneous clinical phenotypes of dominant dystrophic epidermolysis bullosa.
    Murata T; Masunaga T; Shimizu H; Takizawa Y; Ishiko A; Hatta N; Nishikawa T
    Arch Dermatol Res; 2000 Oct; 292(10):477-81. PubMed ID: 11142768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A glycine substitution in the COL7A1 gene causes mild RDEB in a Pakistani family.
    Kraemer L; Wajid M; Christiano AM
    Eur J Dermatol; 2006; 16(6):615-9. PubMed ID: 17229600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretibial epidermolysis bullosa: genetic linkage to COL7A1 and identification of a glycine-to-cysteine substitution in the triple-helical domain of type VII collagen.
    Christiano AM; Lee JY; Chen WJ; LaForgia S; Uitto J
    Hum Mol Genet; 1995 Sep; 4(9):1579-83. PubMed ID: 8541842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression.
    Pourreyron C; Cox G; Mao X; Volz A; Baksh N; Wong T; Fassihi H; Arita K; O'Toole EA; Ocampo-Candiani J; Chen M; Hart IR; Bruckner-Tuderman L; Salas-Alanis JC; McGrath JA; Leigh IM; South AP
    J Invest Dermatol; 2007 Oct; 127(10):2438-44. PubMed ID: 17495952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a de novo glycine substitution in the type VII collagen gene in a proband with mild dystrophic epidermolysis bullosa.
    Cserhalmi-Friedman PB; Grossman J; Karpati S; Ahmad W; Horvath A; Christiano AM
    Exp Dermatol; 1999 Apr; 8(2):143-5. PubMed ID: 10232407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generalized dystrophic epidermolysis bullosa: identification of a novel, homozygous glycine substitution, G2031S, in exon 73 of COL7A1 in monozygous triplets.
    Nordal EJ; Mecklenbeck S; Hausser I; Skranes J; Bruckner-Tuderman L; Gedde-Dahl T
    Br J Dermatol; 2001 Jan; 144(1):151-7. PubMed ID: 11167698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dystrophic epidermolysis bullosa phenotypes in a large consanguineous Tunisian family.
    Ouragini H; Cherif F; Kassar S; Floriddia G; Pascucci M; Daoud W; Osman-Dhahri AB; Boubaker S; Castiglia D; Abdelhak S
    J Dermatol Sci; 2009 May; 54(2):114-20. PubMed ID: 19261445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel and de novo glycine substitution mutations in the type VII collagen gene (COL7A1) in dystrophic epidermolysis bullosa: implications for genetic counseling.
    Rouan F; Pulkkinen L; Jonkman MF; Bauer JW; Cserhalmi-Friedman PB; Christiano AM; Uitto J
    J Invest Dermatol; 1998 Dec; 111(6):1210-3. PubMed ID: 9856843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some, but not all, glycine substitution mutations in COL7A1 result in intracellular accumulation of collagen VII, loss of anchoring fibrils, and skin blistering.
    Hammami-Hauasli N; Schumann H; Raghunath M; Kilgus O; Lüthi U; Luger T; Bruckner-Tuderman L
    J Biol Chem; 1998 Jul; 273(30):19228-34. PubMed ID: 9668111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study.
    Bornert O; Hogervorst M; Nauroy P; Bischof J; Swildens J; Athanasiou I; Tufa SF; Keene DR; Kiritsi D; Hainzl S; Murauer EM; Marinkovich MP; Platenburg G; Hausser I; Wally V; Ritsema T; Koller U; Haisma EM; Nyström A
    J Invest Dermatol; 2021 Apr; 141(4):883-893.e6. PubMed ID: 32946877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A recurrent frameshift mutation in exon 19 of the type VII collagen gene (COL7A1) in Mexican patients with recessive dystrophic epidermolysis bullosa.
    Mellerio JE; Salas-Alanis JC; Amaya-Guerra M; Tamez E; Ashton GH; Mohammedi R; Eady RA; McGrath JA
    Exp Dermatol; 1999 Feb; 8(1):22-9. PubMed ID: 10206718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Premature termination codons on both alleles of the type VII collagen gene (COL7A1) in three brothers with recessive dystrophic epidermolysis bullosa.
    Christiano AM; Suga Y; Greenspan DS; Ogawa H; Uitto J
    J Clin Invest; 1995 Mar; 95(3):1328-34. PubMed ID: 7883979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological correlations of compound heterozygous COL7A1 mutations in recessive dystrophic epidermolysis bullosa.
    Dunnill MG; McGrath JA; Richards AJ; Christiano AM; Uitto J; Pope FM; Eady RA
    J Invest Dermatol; 1996 Aug; 107(2):171-7. PubMed ID: 8757758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a glycine substitution and a splice site mutation in the type VII collagen gene in a proband with mitis recessive dystrophic epidermolysis bullosa.
    Cserhalmi-Friedman PB; Karpati S; Horvath A; Christiano AM
    Arch Dermatol Res; 1997 Oct; 289(11):640-5. PubMed ID: 9444387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.